BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26130719)

  • 1. DDB2 modulates TGF-β signal transduction in human ovarian cancer cells by downregulating NEDD4L.
    Zhao R; Cui T; Han C; Zhang X; He J; Srivastava AK; Yu J; Wani AA; Wang QE
    Nucleic Acids Res; 2015 Sep; 43(16):7838-49. PubMed ID: 26130719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-93 promotes TGF-β-induced epithelial-to-mesenchymal transition through downregulation of NEDD4L in lung cancer cells.
    Qu MH; Han C; Srivastava AK; Cui T; Zou N; Gao ZQ; Wang QE
    Tumour Biol; 2016 Apr; 37(4):5645-51. PubMed ID: 26581907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling.
    Gao S; Alarcón C; Sapkota G; Rahman S; Chen PY; Goerner N; Macias MJ; Erdjument-Bromage H; Tempst P; Massagué J
    Mol Cell; 2009 Nov; 36(3):457-68. PubMed ID: 19917253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H; Zhao J; Vieth E; Nephew KP; Matei D
    Oncotarget; 2016 Dec; 7(51):84453-84467. PubMed ID: 27563817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and Ras signaling pathways.
    Kovacevic Z; Chikhani S; Lui GY; Sivagurunathan S; Richardson DR
    Antioxid Redox Signal; 2013 Mar; 18(8):874-87. PubMed ID: 22462691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage-binding complex recruits HDAC1 to repress Bcl-2 transcription in human ovarian cancer cells.
    Zhao R; Han C; Eisenhauer E; Kroger J; Zhao W; Yu J; Selvendiran K; Liu X; Wani AA; Wang QE
    Mol Cancer Res; 2014 Mar; 12(3):370-80. PubMed ID: 24249678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line.
    Tao J; Shi L; Huang L; Shi H; Chen H; Wang Y; Wang T
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2211-2219. PubMed ID: 28748258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nedd4L modulates the transcription of metalloproteinase-1 and -13 genes to increase the invasive activity of gallbladder cancer.
    Takeuchi T; Adachi Y; Nagayama T; Furihata M
    Int J Exp Pathol; 2011 Apr; 92(2):79-86. PubMed ID: 21039987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
    Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
    Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1.
    Cui T; Srivastava AK; Han C; Wu D; Wani N; Liu L; Gao Z; Qu M; Zou N; Zhang X; Yi P; Yu J; Bell EH; Yang SM; Maloney DJ; Zheng Y; Wani AA; Wang QE
    Cell Death Dis; 2018 May; 9(5):561. PubMed ID: 29752431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nedd4L expression is decreased in ovarian epithelial cancer tissues compared to ovarian non-cancer tissue.
    Yang Q; Zhao J; Cui M; Gi S; Wang W; Han X
    J Obstet Gynaecol Res; 2015 Dec; 41(12):1959-64. PubMed ID: 26554540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway.
    Kim YS; Choi KC; Hwang KA
    Phytomedicine; 2015 Oct; 22(11):993-9. PubMed ID: 26407941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edge: Smad2 and Smad4 regulate TGF-β-mediated Il9 gene expression via EZH2 displacement.
    Wang A; Pan D; Lee YH; Martinez GJ; Feng XH; Dong C
    J Immunol; 2013 Nov; 191(10):4908-12. PubMed ID: 24108699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathobiological properties of the ubiquitin ligase Nedd4L in melanoma.
    Kito Y; Bai J; Goto N; Okubo H; Adachi Y; Nagayama T; Takeuchi T
    Int J Exp Pathol; 2014 Feb; 95(1):24-8. PubMed ID: 24456330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling.
    Chan DW; Hui WW; Wang JJ; Yung MM; Hui LM; Qin Y; Liang RR; Leung TH; Xu D; Chan KK; Yao KM; Tsang BK; Ngan HY
    Oncogene; 2017 Mar; 36(10):1404-1416. PubMed ID: 27593933
    [TBL] [Abstract][Full Text] [Related]  

  • 17.  CUL4B, NEDD4, and UGT1As involve in the TGF-β signalling in hepatocellular carcinoma.
    Qu Z; Li D; Xu H; Zhang R; Li B; Sun C; Dong W; Zhang Y
    Ann Hepatol; 2016; 15(4):568-76. PubMed ID: 27236156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-β stimulates human ovarian cancer cell migration by up-regulating connexin43 expression via Smad2/3 signaling.
    Qiu X; Cheng JC; Zhao J; Chang HM; Leung PC
    Cell Signal; 2015 Oct; 27(10):1956-62. PubMed ID: 26186970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
    Sakashita H; Inoue H; Akamine S; Ishida T; Inase N; Shirao K; Mori M; Mimori K
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S590-8. PubMed ID: 23812770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.